- Home
- FSFG vs TLSA Comparison
FSFG vs TLSA Comparison
Compare FSFG & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSFG
- TLSA
- Stock Information
- Founded
- FSFG 2008
- TLSA 2013
- Country
- FSFG United States
- TLSA United Kingdom
- Employees
- FSFG N/A
- TLSA N/A
- Industry
- FSFG Savings Institutions
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- FSFG Finance
- TLSA Health Care
- Exchange
- FSFG Nasdaq
- TLSA Nasdaq
- Market Cap
- FSFG 177.8M
- TLSA 187.0M
- IPO Year
- FSFG 2008
- TLSA 2000
- Fundamental
- Price
- FSFG $27.64
- TLSA $2.06
- Analyst Decision
- FSFG Strong Buy
- TLSA
- Analyst Count
- FSFG 3
- TLSA 0
- Target Price
- FSFG $31.50
- TLSA N/A
- AVG Volume (30 Days)
- FSFG 17.4K
- TLSA 541.9K
- Earning Date
- FSFG 07-24-2025
- TLSA 05-06-2025
- Dividend Yield
- FSFG 2.31%
- TLSA N/A
- EPS Growth
- FSFG 130.94
- TLSA N/A
- EPS
- FSFG 3.10
- TLSA N/A
- Revenue
- FSFG $79,674,000.00
- TLSA N/A
- Revenue This Year
- FSFG $8.50
- TLSA N/A
- Revenue Next Year
- FSFG $0.15
- TLSA N/A
- P/E Ratio
- FSFG $8.94
- TLSA N/A
- Revenue Growth
- FSFG 10.53
- TLSA N/A
- 52 Week Low
- FSFG $21.63
- TLSA $0.63
- 52 Week High
- FSFG $30.94
- TLSA $2.60
- Technical
- Relative Strength Index (RSI)
- FSFG 64.06
- TLSA 53.26
- Support Level
- FSFG $26.22
- TLSA $1.73
- Resistance Level
- FSFG $26.97
- TLSA $2.53
- Average True Range (ATR)
- FSFG 0.62
- TLSA 0.20
- MACD
- FSFG 0.10
- TLSA -0.05
- Stochastic Oscillator
- FSFG 95.71
- TLSA 41.25
About FSFG First Savings Financial Group Inc.
First Savings Financial Group Inc provides various banking services to individuals and business customers in southern Indiana. The bank accepts deposits from the general public & uses those funds, along with other borrowings, mainly to originate a residential mortgage, commercial mortgage, construction, commercial business, & consumer loans, and to a lesser extent, to invest in mortgage-backed securities and other debt securities. The company conducts lending and deposit activities mainly with individuals and small businesses in its market area. The bank operates in two segments: core banking, which accounts for the majority of revenue, and SBA lending.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.